Company to manufacture drug substance for clinical supply of HaemaLogiX’s lead multiple myeloma drug candidate, KappaMab, at its new state-of-the-art facility in Guangzhou, China
Cipla announced its unaudited consolidated financial results for quarter ended December 31st, 2021.
The company has been manufacturing masks since the Covid-19 outbreak in 2020
Pfizer is evaluating the FDA’s comments and will work with the agency to determine an appropriate path forward
Quviviq is a dual orexin receptor antagonist, which blocks the binding of the wake-promoting neuropeptides orexins and is thought to turn down overactive wakefulness, as opposed to treatments that generally sedate the brain
Biocon has reported consolidated financial results for the period ended December 31, 2021
First launches expected in H1 2022
Ram’s appointment follows the launch of the CDI India division in October 2021.
The extended collaboration will provide services relating to small molecules for both Forbion and BGV portfolio companies active in the biopharmaceutical space
These results will be presented on 21 January at the 2022 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium
Subscribe To Our Newsletter & Stay Updated
